^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Medulloblastoma
    Drug:cisplatin (DNA synthesis inhibitor) +
    cyclophosphamide (Alkylating agent) +
    etoposide IV (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Medulloblastoma: Other Recommended Regimens...cisplatin, etoposide and cyclophosphamide...